Expression of CD38 on CD8 T cells predicts maintenance of high viraemia in HAART-treated HIV-1-infected children

Lancet

Volumn 352, Issue 9144, 1998, Pages 1905-1906

  Viganó, Alessandra ^a   Saresella, Marina ^a   Rusconi, Stefano ^a   Ferrante, Pasquale ^a   Clerici, Mario ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD38 ANTIGEN; CD8 ANTIGEN; DIDANOSINE; LAMIVUDINE; PROTEINASE; RNA DIRECTED DNA POLYMERASE; STAVUDINE; VIRUS RNA; ZIDOVUDINE;

ARTICLE; CHILD; CLINICAL ARTICLE; GENE MUTATION; HEMATOPOIESIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; PROTEIN DOMAIN; T LYMPHOCYTE; VERTICAL TRANSMISSION; VIREMIA;

EID: 0032512268     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)60396-0     Document Type: Article

References (5)

1. 1 Kaufman D, Pantaleo G, Sudre P, et al. CD4 cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART). Lancet 1998; 351: 723-24.
2. 2 Centers for Disease Control: Revised classification system for human immunodeficiency virus infection in children less than 13 years age. MMWR 1994; 43: 1-10.
3. 3 Giorgi JV, Liu Z, Hultin LE, et al. Elevated levels of CD8+CD38+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years follow-up. J AIDS 1993; 6: 904-12.
4. 4 Bofill M, Mocroft A, Lipman M, et al. Increased number of primed activated CD8+CD38+CD45RO+ T cells predict the decline of CD4+ T cells in HIV-1-infected patients. AIDS 1996; 10: 827-34.
5. 5 Sirera R, Bayona A, Carbonelli F, et al. The expression of CD38 and DR markers of immune activation and disease progression in HIV-infected children. XII Intl Conf AIDS. Geneva (Switzerland), June 28-July3, 1998 (abstr 213/31166).